| Company Name: |
BOYAN PHARMA Gold |
| Tel: |
18566078841 18566078841 |
| Email: |
tanyan@boyanpharma.com |
(S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate manufacturers
|
| | (S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Basic information |
| Product Name: | (S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate | | Synonyms: | Carbamic acid, N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester;Carbanic acid,N-[CIS)-1-[3-bromo-6-[3-methyl-3(methyl)sulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-,1,1-dimethylethylester;intermediate of Lenacapavir;(S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate;Tert-butyl (S)-(1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2- 260 yl)-2-(3,5-difluorophenyl)ethyl)carbamate;1,1-Dimethylethyl N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]carbamate;Lenacapavir (GS-6207) Intermediate 2;tert-butyl(S)-(1-(3-bromine-6-(3-methyl-3-(Methylsulfonyl)- 1-Alkyne-1-base)Pyridine-2-base)-2-(3,5-Difluorophenyl)Ethyl)Carbamate | | CAS: | 2189684-54-4 | | MF: | C24H27BrF2N2O4S | | MW: | 557.45 | | EINECS: | | | Product Categories: | | | Mol File: | 2189684-54-4.mol |  |
| | (S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Chemical Properties |
| Boiling point | 636.8±55.0 °C(Predicted) | | density | 1.42±0.1 g/cm3(Predicted) | | pka | 10.37±0.46(Predicted) | | InChIKey | OBUPKGOLRNAZIS-FQEVSTJZSA-N | | SMILES | C(OC(C)(C)C)(=O)N[C@H](C1=NC(C#CC(C)(S(C)(=O)=O)C)=CC=C1Br)CC1=CC(F)=CC(F)=C1 |
| | (S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Usage And Synthesis |
| Uses | (S)-Tert-butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-YN-1-YL)pyridin-2-YL)-2-(3,5-difluorophenyl)ethyl)carbamate is a pharmaceutical intermediate compound that can be used in the preparation of HIV inhibitors. | | Description | (S)-tert-butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate is a key pharmaceutical intermediate for lenapavir (trade name Sunlenca), used in the synthesis of anti-HIV-1 drugs. Lenapavir is a first-in-class long-acting HIV-1 capsid inhibitor administered subcutaneously, providing a prolonged treatment period, significantly reducing the treatment burden on patients, and exhibiting potent antiviral activity against drug-resistant HIV strains. | | References | [1] Rajan, Srinivasan Thirumalai, et al. "Process for the preparation of tert-butyl (S)-(1-(3-bromo-6-(3-methyl-3-(methylsulfonyl) but-1-yn-1-yl) pyridin-2-yl)-2-(3, 5-difluorophenyl) ethyl) carbamate." (2026). |
| | (S)-tert-Butyl (1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Preparation Products And Raw materials |
|